Sj. Rolnick et al., What is the impact of osteoporosis education and bone mineral density testing for postmenopausal women in a managed care setting, MENOPAUSE, 8(2), 2001, pp. 141-148
Citations number
24
Categorie Soggetti
Reproductive Medicine
Journal title
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
Objective: To assess whether osteoporosis education, with and without bone
mineral density (BMD) testing, increases the initiation of lifestyle change
s and pharmaceutical treatment to prevent osteoporosis.
Design: A total of 508 women, aged 54-65, from a large managed care organiz
ation who were not on osteoporosis prevention therapy participated in an in
tervention study. Participants were randomly assigned to either an educatio
n class on osteoporosis (n = 301) or education plus BMD (n = 207). A contro
l group of 187 women receiving no intervention were also surveyed to serve
as comparison. Group differences and differences based on BMD test result w
ere compared 6 months after education regarding self-reported changes in he
alth behaviors using chi (2) tests and logistic regression analyses.
Results: Of the 508 intervention participants, 455 (90%) responded to the f
ollow-up survey. Initiation of hormone replacement therapy was reported by
9%, with 5% reporting starting alendronate. More than half reported changes
in diet, exercise, or calcium intake. Forty-three percent increased their
vitamin D intake. There were no significant group differences in behavior e
xcept with regard to pharmaceutical therapy; subjects with education plus B
MD were three times more likely than those receiving education only to repo
rt starting hormone replacement therapy (p = 0.004). Low BMD scores were as
sociated with increasing vitamin D intake (p = 0.03) and starting medicatio
n (p = 0.001). Women in the intervention groups were significantly more lik
ely to report modifying their diet (p < 0.001), calcium (p < 0.01), and vit
amin D intake (p < 0.0001) than women in the control group, not exposed to
education.
Conclusion: Education regarding osteoporosis prevention seems to encourage
women to make lifestyle changes. The inclusion of BMD testing enhances the
likelihood that women will consider pharmaceutical therapy.